Literature DB >> 11697340

ABL-BCR expression does not correlate with deletions on the derivative chromosome 9 or survival in chronic myeloid leukemia.

J de la Fuente, K Merx, E J Steer, M Müller, R M Szydlo, O Maywald, U Berger, R Hehlmann, J M Goldman, N C Cross, J V Melo, A Hochhaus.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11697340     DOI： 10.1182/blood.v98.9.2879

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  3 in total

1.  Reciprocal t(9;22) ABL/BCR fusion proteins: leukemogenic potential and effects on B cell commitment.

Authors:  Xiaomin Zheng; Claudia Oancea; Reinhard Henschler; Malcolm A S Moore; Martin Ruthardt
Journal:  PLoS One       Date:  2009-10-30       Impact factor: 3.240

2.  Prognostic impact of deletions of derivative chromosome 9 in patients with chronic myelogenous leukemia treated with nilotinib or dasatinib.

Authors:  Alfonso Quintás-Cardama; Hagop Kantarjian; Jianqin Shan; Elias Jabbour; Lynne V Abruzzo; Srdan Verstovsek; Guillermo Garcia-Manero; Susan O'Brien; Jorge Cortes
Journal:  Cancer       Date:  2011-04-26       Impact factor: 6.860

Review 3.  Signaling lymphocytic activation molecules Slam and cancers: friends or foes?

Authors:  Gregory Fouquet; Ingrid Marcq; Véronique Debuysscher; Jagadeesh Bayry; Amrathlal Rabbind Singh; Abderrahmane Bengrine; Eric Nguyen-Khac; Mickael Naassila; Hicham Bouhlal
Journal:  Oncotarget       Date:  2018-02-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.